Treatment patterns and disease burden of hypereosinophilic syndrome (HES) in the United States: A real-world observational, retrospective cohort study☆
Thanai Pongdee, Paul Dolin, Bo Ding, Amanda M. Moore, Priya Jain, Jennifer Rowell, Christopher Edmonds, James M. Eudicone, Thomas Peer, Kinwei Arnold Chan, Stephanie Yanjing Chen · 2026
Read Treatment patterns and disease burden of hypereosinophilic syndrome (HES) in the United States: A real-world observational, retrospective cohort study☆ by Thanai Pongdee, Paul Dolin, Bo Ding, Amanda M. Moore, Priya Jain, Jennifer Rowell, Christopher Edmonds, James M. Eudicone, Thomas Peer, Kinwei Arnold Chan, Stephanie Yanjing Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13571313.txt.
Description
Thanai Pongdee and co-authors describe treatment patterns and burden for a rare blood disorder in the United States in a 2026 study. Hypereosinophilic syndrome involves lasting high counts of a white cell type that damages organs. Steroid pills have long been the main treatment for its two main subtypes, but long use brings toxicity, and newer biologic drugs still leave gaps.
Using linked health records and claims, the team followed one hundred ten patients for up to two years. On average nearly three organ systems were involved at the start. Half the patients had no treatment within two years, and steroids were the most used therapy. Fewer than forty percent reached full remission. Among new cases, years often passed between the first high cell count and diagnosis. The authors call for earlier detection and better options.
Catalog record
| CREATOR | Thanai Pongdee, Paul Dolin, Bo Ding, Amanda M. Moore, Priya Jain, Jennifer Rowell, Christopher Edmonds, James M. Eudicone, Thomas Peer, Kinwei Arnold Chan, Stephanie Yanjing Chen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |